Patents by Inventor Robert Erwin

Robert Erwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050005319
    Abstract: The present invention provides methods for rapidly determining the function of nucleic acid sequences by transfecting the same into a host organism to effect expression. Phenotypic and biochemical changes produced thereby are then analyzed to ascertain the function of the nucleic acids which have been transfected into the host organism. The invention also provides methods for silencing endogenous genes by transfecting hosts with nucleic acid sequences to effect expression of the same. The present invention also provides methods for selecting desired functions of RNAs and proteins by the use of virus vectors to express libraries of nucleic acid sequence variants. Moreover, the present invention provides methods for inhibiting an endogenous protease of a plant host.
    Type: Application
    Filed: July 16, 2004
    Publication date: January 6, 2005
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Guy della-Cioppa, Robert Erwin, Wayne Fitzmaurice, Kathleen Hanley, Moaro Kumagai, John Lindbo, David McGee, Hal Padgett, Gregory Pogue
  • Patent number: 4156739
    Abstract: The subject invention is directed to compounds having the formula: ##STR1## wherein R.sub.1 and R.sub.2 are H, alkyl or combinations thereof,R.sub.3 and R.sub.4 are H, halogen, amino, alkylamino, alkoxy, alkyl, OH, O, NO.sub.2 or combinations thereof, and X is CH or N, which compounds are useful as anti-hypertensive agents.
    Type: Grant
    Filed: September 19, 1977
    Date of Patent: May 29, 1979
    Assignee: Research Corporation
    Inventors: Kenneth R. Fountain, Terry Early, Horst Kehl, Robert Erwin
  • Patent number: 4083864
    Abstract: The subject invention is directed to a method of making compounds having the formula: ##STR1## wherein R.sub.1 is alkyl, R.sub.2 is H or alkyl, R.sub.3 and R.sub.4 are H, halogen, amino, alkylamino, alkoxy, alkyl, OH, O, NO.sub.2 or combinations thereof, and X is CH or N, which compounds are useful as antihypertensive agents.
    Type: Grant
    Filed: June 1, 1976
    Date of Patent: April 11, 1978
    Assignee: Research Corporation
    Inventor: Robert Erwin